Transplacental transfer and metabolism of buprenorphine in preterm human placenta

American Journal of Perinatology

Volumn 28, Issue 1, 2011, Pages 25-32

  Fokina, Valentina M ^a   Patrikeeva, Svetlana L ^a   Zharikova, Olga L ^a   Nanovskaya, Tatiana N ^a   Hankins, Gary V D ^a   Ahmed, Mahmoud S ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Buprenorphine; metabolism; pregnant addict; preterm; transplacental transfer

Indexed keywords

BUPRENORPHINE; CYTOCHROME P450; ISOTOPE;

ARTICLE; BIOTRANSFORMATION; DRUG METABOLISM; FEMALE; GESTATIONAL AGE; HUMAN; LIQUID CHROMATOGRAPHY; LIQUID SCINTILLATION COUNTING; MASS SPECTROMETRY; MICROSOME; PLACENTAL TRANSFER; PREMATURITY; PRIORITY JOURNAL; SCINTILLATION SPECTROMETRY; THIRD TRIMESTER PREGNANCY; TROPHOBLAST;

ANTIBODIES, MONOCLONAL; AROMATASE; ARYL HYDROCARBON HYDROXYLASES; BIOTRANSFORMATION; BUPRENORPHINE; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GESTATIONAL AGE; HUMANS; MICROSOMES; OXIDOREDUCTASES, N-DEMETHYLATING; PERFUSION; PLACENTA; PREGNANCY;

EID: 78650587999     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0030-1262508     Document Type: Article

References (27)

1. Johnson R E., Jones H E., Fischer G. Use of buprenorphine in pregnancy: patient management and effects on the neonate. Drug Alcohol Depend 2003 70 2 Suppl S87-S101
2. Jones H E., Johnson R E., Jasinski D R. et al. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Depend 2005 79 1-10
3. Nanovskaya T N., Deshmukh S, Brooks M, Ahmed M S. Transplacental transfer and metabolism of buprenorphine. J Pharmacol Exp Ther 2002 300 26-33
4. Nekhayeva I A., Nanovskaya T N., Deshmukh S V., Zharikova O L., Hankins G DV, Ahmed M S. Bidirectional transfer of methadone across human placenta. Biochem Pharmacol 2005 69 187-197
5. Pasanen M, Pelkonen O. The expression and environmental regulation of P450 enzymes in human placenta. Crit Rev Toxicol 1994 24 211-229
6. Deshmukh S V., Nanovskaya T N., Ahmed M S. Aromatase is the major enzyme metabolizing buprenorphine in human placenta. J Pharmacol Exp Ther 2003 306 1099-1105
7. Miller R K., Koszalka T R., Brent R L. The transport of molecules across placental membranes. In: Poste G Nicolson GL eds. The Cell Surface in Animal Embryogenesis and Development. Amsterdam, New York, Oxford North-Holland Publishing Company 1976 145-223
8. Hakkola J, Pasanen M, Hukkanen J et al. Expression of xenobiotic-metabolizing cytochrome P450 forms in human full-term placenta. Biochem Pharmacol 1996 51 403-411 (Pubitemid 26071173)
9. Hakkola J, Raunio H, Purkunen R et al. Detection of cytochrome P450 gene expression in human placenta in first trimester of pregnancy. Biochem Pharmacol 1996 52 379-383
10. Kitawaki J, Yoshida N, Osawa Y. An enzyme-linked immunosorbent assay for quantitation of aromatase cytochrome P-450. Endocrinology 1989 124 1417-1423
11. Kitawaki J, Inoue S, Tamura T et al. Increasing aromatase cytochrome P-450 level in human placenta during pregnancy: studied by immunohistochemistry and enzyme-linked immunosorbent assay. Endocrinology 1992 130 2751-2757
12. Miller R K., Wier P J., Maulik D, di Sant'Agnese P A. Human placenta in vitro: characterization during 12 h of dual perfusion. Contrib Gynecol Obstet 1985 13 77-84
13. Nanovskaya T N., Nekhayeva I A., Hankins G D., Ahmed M S. Transfer of methadone across the dually perfused preterm human placental lobule. Am J Obstet Gynecol 2008 198 126.e1-4
14. Walsh S L., Preston K L., Stitzer M L., Cone E J., Bigelow G E. Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clin Pharmacol Ther 1994 55 569-580
15. Jagsch R, Gombas W, Schindler S D., Eder H, Moody D E., Fischer G. Opioid plasma concentrations in methadone-and buprenorphine-maintained patients. Addict Biol 2005 10 365-371
16. Hieronymus T L., Nanovskaya T N., Deshmukh S V., Vargas R, Hankins G DV, Ahmed M S. Methadone metabolism by early gestational age placentas. Am J Perinatol 2006 23 287-294
17. Konje J C., Kaufmann P, Bell S C., Taylor D J. A longitudinal study of quantitative uterine blood flow with the use of color power angiography in appropriate for gestational age pregnancies. Am J Obstet Gynecol 2001 185 608-613
18. Bassily M, Ghabrial H, Smallwood R A., Morgan D J. Determinants of placental drug transfer: studies in the isolated perfused human placenta. J Pharm Sci 1995 84 1054-1060
19. Nanovskaya T, Nekhayeva I, Karunaratne N, Audus K, Hankins G D., Ahmed M S. Role of P-glycoprotein in transplacental transfer of methadone. Biochem Pharmacol 2005 69 1869-1878
20. Nekhayeva I A., Nanovskaya T N., Hankins G D., Ahmed M S. Role of human placental efflux transporter P-glycoprotein in the transfer of buprenorphine, levo-alpha-acetylmethadol, and paclitaxel. Am J Perinatol 2006 23 423-430
21. Nishimura M, Yaguti H, Yoshitsugu H, Naito S, Satoh T. Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR. Yakugaku Zasshi 2003 123 369-375
22. Bièche I, Narjoz C, Asselah T et al. Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues. Pharmacogenet Genomics 2007 17 731-742
23. Zharikova O L., Deshmukh S V., Kumar M et al. The effect of opiates on the activity of human placental aromatase/CYP19. Biochem Pharmacol 2007 73 279-286
24. Iribarne C, Picart D, Dréano Y, Bail J P., Berthou F. Involvement of cytochrome P450 3A4 in N-dealkylation of buprenorphine in human liver microsomes. Life Sci 1997 60 1953-1964
25. Kobayashi K, Yamamoto T, Chiba K et al. Human buprenorphine N-dealkylation is catalyzed by cytochrome P450 3A4. Drug Metab Dispos 1998 26 818-821
26. Picard N, Cresteil T, Djebli N, Marquet P. In vitro metabolism study of buprenorphine: evidence for new metabolic pathways. Drug Metab Dispos 2005 33 689-695
27. Moody D E., Slawson M H., Strain E C., Laycock J D., Spanbauer A C., Foltz R L. A liquid chromatographic-electrospray ionization-tandem mass spectrometric method for determination of buprenorphine, its metabolite, norbuprenorphine, and a coformulant, naloxone, that is suitable for in vivo and in vitro metabolism studies. Anal Biochem 2002 306 31-39